As of and for the Three Months Ended March 31, 2025

As Previously

Reported

Adjustment

As Revised

Discontinued

Operations

As Reported

Consolidated Statement of Operations:

Telehealth revenue, net

$

52,456,481

$

(1,568,582

)

$

50,887,899

$

-

$

50,887,899

Total revenues, net

$

65,697,756

$

(1,568,582

)

$

64,129,174

$

13,241,275

$

50,887,899

Gross profit

$

57,054,040

$

(1,568,582

)

$

55,485,458

$

12,734,021

$

42,751,437

Operating income (loss)

$

2,542,924

$

(1,568,582

)

$

974,342

$

2,156,059

$

(1,181,717

)

Net income

$

1,916,649

$

(1,568,582

)

$

348,067

$

-

$

348,067

Net income (loss) attributable to LifeMD, Inc.

$

1,384,804

$

(1,568,582

)

$

(183,778

)

$

-

$

(183,778

)

Net income (loss) attributable to LifeMD, Inc. common stockholders

$

608,241

$

(1,568,582

)

$

(960,341

)

$

-

$

(960,341

)

Basic earnings (loss) per share attributable to LifeMD, Inc. common stockholders

$

0.01

$

(0.03

)

$

(0.02

)

$

-

$

(0.02

)

Diluted earnings (loss) per share attributable to LifeMD, Inc. common stockholders

$

0.01

$

(0.03

)

$

(0.02

)

$

-

$

(0.02

)

Consolidated Statement of Changes in Stockholders’ Equity (Deficit):

Accumulated deficit

$

235,644,977

$

5,166,295

$

240,811,272

$

-

$

240,811,272

Non-controlling interest

$

(1,935,978

)

$

(88,961

)

$

(2,024,939

)

$

-

$

(2,024,939

)

Consolidated Statement of Cash Flows:

Net income

$

1,916,649

$

(1,568,582

)

$

348,067

$

-

$

348,067

Accounts receivable

$

(1,974,961

)

$

1,507,106

$

(467,855

)

$

(7,907

)

$

(459,948

)

Deferred revenue

$

144,985

$

61,475

$

206,460

$

9,126

$

197,334

Net cash provided by operating activities

$

3,068,387

$

-

$

3,068,387

$

-

$

3,068,387